Clinical-stage gene-therapy company Genprex (NASDAQ: GNPX) is at the forefront to advance innovative developments in the war against lung cancers, testing its trademarked Oncoprex immunogene therapy. A recent article discussing this reads, “Oncoprex’s phase I and II clinical-stage trial therapies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles,…
Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) this morning announced that it will host a conference call on Tuesday, April 16, 2019, at 1:00 p.m. ET to discuss its financial results for the quarter and year ended December 31, 2018. Per the update, the call will be hosted by Youngevity’s senior management, including…
Lifestyle-oriented cannabis company Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) this morning announced that it has reached an agreement with Aphria Inc. (TSX: APHA) (NYSE: APHA) to shorten the expiry time for acceptance of its formal offer to acquire all of the issued and outstanding common shares of Aphria from 5:00 p.m. ET on…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) this morning announced that it has retained Oak Hill Financial Inc. to provide investor relations services to the company in compliance with regulatory guidelines. Per the update, Oak Hill is a Toronto-based firm that develops strategic platforms for its clients that…
Khrysos Industries, a subsidiary of leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI), recently acquired 45 acres of land for research and development. A recent article discussing the company reads, “The company, which has been named among the ‘Top 100 Global Direct Selling Companies,’ holds a diversified portfolio of goods and services in a variety…
Los Angeles, California-based cannabis firm Cannabis Strategic Ventures’ (OTC: NUGS) subsidiary BudHire is ideally positioned to take advantage of the rising demand for outsourced personnel solutions. A recent article discussing NUGS reads, “Supporting this rapidly growing industry is the prime strategy of Cannabis Strategic Ventures. Among the company’s subsidiaries is the aptly named BudHire, an…
Ontario-based VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of first-class cannabis products and services to the medical and adult-use markets, announced on Wednesday that it intends to post the company’s financial and operating results for the fiscal fourth quarter and full year 2018 before the markets open on April 30, 2019. To view…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday announced that its website, TGOD.ca, was recognized with two prestigious global awards. According to the update, the honors include two Horizon Interactive Awards in the categories of “Best Responsive / Mobile Website (Gold)” and “Best E-commerce Website (Bronze).” Since…
TransCanna Holdings (CSE: TCAN) (FSE: TH8), an emerging cannabis branding, transportation and distribution company based in Canada, this morning provided an update concerning the company’s acquisition of a 196,000-square-foot vertically integrated cannabis facility. Per the update, TransCanna expects the closing of escrow for the acquisition to take place on or around Monday, April 15th. The company…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced its successful negotiation of renewal management contracts with chief executive officer Chris Bunka and president John Docherty. According to the update, the new 3-year term contracts, for which specific details can be found within regulatory filings, provide management continuity…
Clinical-stage gene therapy company Genprex Inc. (NASDAQ: GNPX) this morning announced that its collaborators from the University of Texas MD Anderson Cancer Center (“MD Anderson”) detailed positive preclinical data, in a poster presented at the American Association of Cancer Research Meeting 2019, regarding the combination of the TUSC2 gene with an anti-PD1 antibody, pembrolizumab, for…
Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative drug-delivery platform DehydraTECH(TM) alters the way cannabinoids enter the bloodstream, which results in increased absorption. A recent article discussing LXRP reads, “Its proprietary technology promises multiple advantages in cannabinoid edibles. First, it masks the undesirable taste typically found in cannabinoid edibles, eliminating the need to add…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently received its second organic certification at its Hamilton facility. A recent article discussing the company reads, “Organic certification is a big deal for TGOD, big enough for the company to enshrine the concept in its name. Organic cultivation leads…
Canada-based cannabis company TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) late Thursday announced that it has closed its previously detailed and upsized brokered private placement of units, generating gross proceeds of C$16 million. Per the update, an aggregate of eight million units of the company were sold at a price of C$2.00 per unit, with…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) on Monday provided a clinical, corporate and financial update for the year ended December 31, 2018. Among other highlights, Genprex reached various milestones in 2018 and early 2019 which included completing its initial public offering (“IPO”) and listing of common stock on NASDAQ Capital Market, completing a $10…
Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) today announced that it has executed a one-year supply and processing agreement to produce 99 percent pure CBD (no THC) isolate. The company expects to begin shipping under the contract this month and continue in equal amounts through March 2020. “The Khrysos Industries business model is…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, James E. Wagner Cultivation Corporation (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF), has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (“JWC2”). Per the update, reception of this license will result in the launch of the initial phase…
Global technology and value-added solutions group Net Element (NASDAQ: NETE), through its wholly owned subsidiary Aptito, delivers comprehensive business-management solutions and cloud-based point of sale (“POS”) for the restaurant industry. A recent article discussing the company reads, “A quality POS system ensures quality service, whether it’s used in a gourmet restaurant or a quick service…
Biotechnology company and drug-delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) utilizes disruptive technology for the improved delivery of bioactive compounds. A recent article discussing this reads, “Lexaria’s technology has been shown to be effective in numerous global studies, significantly assisting rapidity and quantity of absorption for a range of lipophilic (fat-soluble), bioactive molecules.…
Los Angeles, California-based Cannabis Strategic Ventures (OTC: NUGS) is leveraging a diverse brand portfolio to grab opportunity and garner a corner of the $10 billion cannabis and $900 million hemp industries. A recent article discussing this reads, “One of its major subsidiaries, Pure Applied Sciences Inc., has cultivated a rich portfolio of ultra-high quality products.…